Answers are grounded in this paper and cite their sources.
Background Spinal muscular atrophy (SMA) is caused by the loss of the survival motor neuron 1 ( SMN1 ) gene, resulting in the degeneration of the anterior horn cells of the spinal cord. SMA is known as a motor neuron disease; however, there are numerous reports on complications associated with the gastrointestinal tract, including the gastroesophageal reflex, delayed gastric emptying, and constipation. Case presentation Here, we report a case of a 7-year-old girl with type 1 SMA who developed pneumatosis cystoides intestinalis, a rare gastrointestinal complication of SMA, followed by severe gastrointestinal dysmotility. Severe gastrointestinal dysmotility makes tube feeding difficult, resulting in weight loss and difficulty in weaning from parenteral to enteral nutrition for 8 months. As the nutritional status deteriorated, the compound muscle action potential (CMAP) amplitude also showed a decreasing trend, leading to a change in disease-modifying therapies (DMTs) from nusinersen to risdiplam. Gastrointestinal motility and CMAP amplitude gradually improved as nutritional status improved. Discussion/Conclusion Patients with severe type of SMA who have low SMN2 copy numbers occasionally present with severe gastrointestinal complications. Severe nutritional deficiencies may contribute to worsening of SMA disease progression and may potentially attenuate the therapeutic effects of DMTs, highlighting the need for careful clinical attention.
No takes yet. Share an insight, caveat, or question.
Goda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: